BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21900234)

  • 1. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
    Bate C; Williams A
    J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glimepiride protects neurons against amyloid-β-induced synapse damage.
    Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
    Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
    Bate C; Williams A
    Prion; 2012; 6(4):350-3. PubMed ID: 22895089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cholesterol ester cycle regulates signalling complexes and synapse damage caused by amyloid-β.
    West E; Osborne C; Bate C
    J Cell Sci; 2017 Sep; 130(18):3050-3059. PubMed ID: 28760925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.
    Nolan W; McHale-Owen H; Bate C
    Biochem J; 2017 Aug; 474(17):3045-3058. PubMed ID: 28729427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage.
    Bate C; Williams A
    Neuropharmacology; 2011 Dec; 61(8):1406-12. PubMed ID: 21903110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.
    Rushworth JV; Griffiths HH; Watt NT; Hooper NM
    J Biol Chem; 2013 Mar; 288(13):8935-51. PubMed ID: 23386614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-β oligomers released from 7PA2 cells.
    Williams RSB; Bate C
    Neuropharmacology; 2018 Jan; 128():54-62. PubMed ID: 28947378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal transcriptome, tau and synapse loss in Alzheimer's knock-in mice require prion protein.
    Stoner A; Fu L; Nicholson L; Zheng C; Toyonaga T; Spurrier J; Laird W; Cai Z; Strittmatter SM
    Alzheimers Res Ther; 2023 Nov; 15(1):201. PubMed ID: 37968719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
    Bate C; Williams A
    J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers.
    McHale-Owen H; Bate C
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):649-659. PubMed ID: 29247837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
    Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
    Williams RS; Bate C
    Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage.
    West E; Osborne C; Nolan W; Bate C
    Biology (Basel); 2015 Jun; 4(2):367-82. PubMed ID: 26043272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegeneration induced by clustering of sialylated glycosylphosphatidylinositols of prion proteins.
    Bate C; Williams A
    J Biol Chem; 2012 Mar; 287(11):7935-44. PubMed ID: 22262833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein.
    Balducci C; Beeg M; Stravalaci M; Bastone A; Sclip A; Biasini E; Tapella L; Colombo L; Manzoni C; Borsello T; Chiesa R; Gobbi M; Salmona M; Forloni G
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2295-300. PubMed ID: 20133875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
    Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
    Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking the Cycle, Cholesterol Cycling, and Synapse Damage in Response to Amyloid-β.
    Bate C
    J Exp Neurosci; 2017; 11():1179069517733096. PubMed ID: 29238218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of cellular prion protein (PrP(C)) prevents cognitive dysfunction and apoptotic neuronal cell death induced by amyloid-β (Aβ₁₋₄₀) administration in mice.
    Rial D; Piermartiri TC; Duarte FS; Tasca CI; Walz R; Prediger RD
    Neuroscience; 2012 Jul; 215():79-89. PubMed ID: 22537845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.